The Clorox Company provided earnings guidance for the year 2022. For the year, the company 2022 fiscal year sales are projected to be down 2% to 6%, reflecting lower sales in the first half – from the high single digits to low double digits – due to comparisons to 27% sales growth in the first half of fiscal year 2021. In the second half of the fiscal year, sales are expected to normalize toward the lower end of the company's long-term sales growth target of 3% to 5%. The company expects the large factor impacting its sales performance in fiscal year 2022 to be consumer demand, which remains uncertain. Fiscal year organic sales are projected to be down 2% to 6%. The company anticipates fiscal year 2022 diluted EPS to be between $5.05 and $5.35, a decrease of between 9% and 4%, respectively.